$SLS
SELLAS Life Sciences Group, Inc. Stock $sls

$sls Overview Financials Valuation SEC Filings Company Website

2014 Q1 Form 10-K Financial Statement

#000139047814000016 Filed on March 17, 2014

Income Statement

Concept	2014 Q1	2013 Q4	2012 Q4
Revenue	$2.173M	$1.436M	$1.436M
YoY Change	-20.98%	0.0%
Cost Of Revenue	$331.0K	$220.0K
YoY Change
Gross Profit	$1.842M	$1.229M	$1.229M
YoY Change	-21.85%	0.0%
Gross Profit Margin	84.77%	85.58%	85.58%
Selling, General & Admin	$6.830M	$6.230M	$1.470M
YoY Change	346.41%	323.81%	-2.0%
% of Gross Profit	370.79%	506.92%	119.61%
Research & Development	$6.770M	$7.090M	$4.110M
YoY Change	33.24%	72.51%	96.65%
% of Gross Profit	367.54%	576.89%	334.42%
Depreciation & Amortization	$232.0K	$120.0K	$0.00
YoY Change	11500.0%		-100.0%
% of Gross Profit	12.6%	9.76%	0.0%
Operating Expenses	$13.60M	$13.45M	$5.580M
YoY Change	105.72%	141.04%	55.43%
Operating Profit	-$11.85M	-$12.22M	-$4.351M
YoY Change	79.23%	180.88%
Interest Expense	$9.480M	-$34.66M	$0.00
YoY Change	-289.6%
% of Operating Profit
Other Income/Expense, Net	-$2.536M	-$380.0K	$770.0K
YoY Change	-78.96%	-149.35%	-89.54%
Pretax Income	-$2.540M	-$47.39M	-$4.800M
YoY Change	-78.93%	887.29%	-227.32%
Income Tax	$0.00	$1.110M	-$1.050M
% Of Pretax Income
Net Earnings	-$2.536M	-$5.516M	-$19.68M
YoY Change	-84.62%	-71.97%	-1337.61%
Net Earnings / Revenue	-116.71%	-384.12%	-1370.33%
Basic Earnings Per Share		-$0.51	-$2.51
Diluted Earnings Per Share	-$654.5M	-$13.64B	-$1.618B
COMMON SHARES
Basic Shares Outstanding	117.9M shares	105.2M shares	67.63M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q1	2013 Q4	2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$52.40M	$47.79M	$35.49M
YoY Change	92.72%	34.67%	211.27%
Cash & Equivalents	$52.43M	$47.79M	$32.81M
Short-Term Investments		$0.00	$2.678M
Other Short-Term Assets	$1.500M	$1.600M	$600.0K
YoY Change	400.0%	166.67%	50.0%
Inventory	$358.0K	$386.0K	$0.00
Prepaid Expenses
Receivables	$1.466M	$3.683M	$0.00
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$55.78M	$68.79M	$36.12M
YoY Change	102.82%	90.43%	205.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$653.0K	$314.0K	$29.00K
YoY Change	2318.52%	982.76%	-92.62%
Goodwill	$5.898M	$5.898M	$5.898M
YoY Change	0.0%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$100.0K	$100.0K	$100.0K
YoY Change	0.0%	0.0%
Total Long-Term Assets	$36.51M	$19.19M	$18.87M
YoY Change	7.55%	1.73%	-1.53%
TOTAL ASSETS
Total Short-Term Assets	$55.78M	$68.79M	$36.12M
Total Long-Term Assets	$36.51M	$19.19M	$18.87M
Total Assets	$92.29M	$87.98M	$54.99M
YoY Change	50.18%	60.0%	77.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.574M	$1.907M	$1.976M
YoY Change	-25.86%	-3.49%	-8.31%
Accrued Expenses	$9.793M	$4.841M	$2.038M
YoY Change	30.96%	137.54%	-6.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$3.102M	$2.149M	$0.00
YoY Change
Total Short-Term Liabilities	$26.84M	$62.47M	$15.92M
YoY Change	1.75%	292.44%	42.11%
LONG-TERM LIABILITIES
Long-Term Debt	$6.883M	$7.743M	$0.00
YoY Change	6783.0%
Other Long-Term Liabilities	$7.000M	$6.800M	$6.200M
YoY Change	4.48%	9.68%	34.78%
Total Long-Term Liabilities	$6.883M	$7.743M	$0.00
YoY Change	1.22%		-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$26.84M	$62.47M	$15.92M
Total Long-Term Liabilities	$6.883M	$7.743M	$0.00
Total Liabilities	$45.79M	$82.09M	$27.23M
YoY Change	20.05%	201.47%	30.56%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$231.8M	$188.6M	$132.2M
YoY Change	74.58%	42.7%	62.8%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$3.849M	$3.849M	$3.849M
YoY Change	0.0%	0.0%	0.0%
Treasury Stock Shares	675.0K shares	675.0K shares	675.0K shares
Shareholders Equity	$46.50M	$5.886M	$27.76M
YoY Change
Total Liabilities & Shareholders Equity	$92.29M	$87.98M	$54.99M
YoY Change	50.18%	60.0%	77.56%

Cashflow Statement

Concept	2014 Q1	2013 Q4	2012 Q4
OPERATING ACTIVITIES
Net Income	-$2.536M	-$5.516M	-$19.68M
YoY Change	-84.62%	-71.97%	-1337.61%
Depreciation, Depletion And Amortization	$232.0K	$120.0K	$0.00
YoY Change	11500.0%		-100.0%
Cash From Operating Activities	-$8.048M	-$8.490M	-$5.170M
YoY Change	50.97%	64.22%	23.98%
INVESTING ACTIVITIES
Capital Expenditures	$22.00K	-$5.220M
YoY Change
Acquisitions	$0.00	$10.00M
YoY Change	-100.0%
Other Investing Activities	$0.00	$2.420M	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$2.032M	-$2.800M	$0.00
YoY Change	-79.86%		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00
YoY Change
Debt Paid & Issued, Net	$3.000K
YoY Change
Cash From Financing Activities	$14.72M	7.690M	22.56M
YoY Change	15900.0%	-65.91%	225500.0%
NET CHANGE
Cash From Operating Activities	-$8.048M	-8.490M	-5.170M
Cash From Investing Activities	-$2.032M	-2.800M	0.000
Cash From Financing Activities	$14.72M	7.690M	22.56M
Net Change In Cash	$4.640M	-3.600M	17.39M
YoY Change	-130.28%	-120.7%	-507.26%
FREE CASH FLOW
Cash From Operating Activities	-$8.048M	-$8.490M	-$5.170M
Capital Expenditures	$22.00K	-$5.220M
Free Cash Flow	-$8.070M	-$3.270M
YoY Change	51.38%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1976000	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2660000	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3683000	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2038000	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8667000	USD
CY2013Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	713000	USD
CY2012Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	116000	USD
CY2012Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	0	USD
CY2013Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	158000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1626000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	132168000	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	188600000	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Nonvested Shares Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationNonvestedSharesRequisiteServicePeriodRecognition	2774000	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Nonvested Shares Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationNonvestedSharesRequisiteServicePeriodRecognition	794000	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	600000	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	-15000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	644000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	1886000	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	-7286000	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	-12709000	USD
CY2011	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2525000	USD
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2904000	USD
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1759000	USD
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	131000	USD
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	28009000	shares
CY2012	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20888000	shares
CY2012Q4	us-gaap	Assets Assets	54986000	USD
CY2013Q4	us-gaap	Assets Assets	87976000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	53455000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	36121000	USD
CY2013Q4	us-gaap	Business Acquisition Contingent Consideration At Fair Value BusinessAcquisitionContingentConsiderationAtFairValue	6821000	USD
CY2012Q4	us-gaap	Business Acquisition Contingent Consideration At Fair Value BusinessAcquisitionContingentConsiderationAtFairValue	7142000	USD
CY2013Q4	us-gaap	Business Acquisition Contingent Consideration At Fair Value Current BusinessAcquisitionContingentConsiderationAtFairValueCurrent	0	USD
CY2012Q4	us-gaap	Business Acquisition Contingent Consideration At Fair Value Current BusinessAcquisitionContingentConsiderationAtFairValueCurrent	935000	USD
CY2013Q4	us-gaap	Business Acquisition Contingent Consideration Potential Cash Payment BusinessAcquisitionContingentConsiderationPotentialCashPayment	30000000	USD
CY2011Q2	us-gaap	Business Acquisition Contingent Consideration Potential Cash Payment BusinessAcquisitionContingentConsiderationPotentialCashPayment	32000000	USD
CY2011Q2	us-gaap	Business Acquisition Effective Date Of Acquisition1 BusinessAcquisitionEffectiveDateOfAcquisition1	2011-04-13
CY2011Q2	us-gaap	Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued	5000000	shares
CY2011	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.12
CY2012Q4	us-gaap	Business Acquisition Purchase Price Allocation Assets Acquired Liabilities Assumed Net BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet	0	USD
CY2013Q4	us-gaap	Business Acquisition Purchase Price Allocation Assets Acquired Liabilities Assumed Net BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet	0	USD
CY2011Q4	us-gaap	Business Acquisition Purchase Price Allocation Assets Acquired Liabilities Assumed Net BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet	12827000	USD
CY2011Q4	us-gaap	Business Acquisition Purchase Price Allocation Current Assets Cash And Cash Equivalents BusinessAcquisitionPurchasePriceAllocationCurrentAssetsCashAndCashEquivalents	168000	USD
CY2011Q4	us-gaap	Business Acquisition Purchase Price Allocation Current Assets Prepaid Expense And Other Assets BusinessAcquisitionPurchasePriceAllocationCurrentAssetsPrepaidExpenseAndOtherAssets	14000	USD
CY2011Q4	us-gaap	Business Acquisition Purchase Price Allocation Current Liabilities Accounts Payable BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesAccountsPayable	931000	USD
CY2011Q4	us-gaap	Business Acquisition Purchase Price Allocation Current Liabilities Accrued Liabilities BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesAccruedLiabilities	143000	USD
CY2011Q4	us-gaap	Business Acquisition Purchase Price Allocation Deferred Tax Liabilities Noncurrent BusinessAcquisitionPurchasePriceAllocationDeferredTaxLiabilitiesNoncurrent	5053000	USD
CY2011Q4	us-gaap	Business Acquisition Purchase Price Allocation Equipment BusinessAcquisitionPurchasePriceAllocationEquipment	11000	USD
CY2011Q4	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Amount BusinessAcquisitionPurchasePriceAllocationGoodwillAmount	5898000	USD
CY2011Q4	us-gaap	Business Acquisition Purchase Price Allocation Notes Payable And Long Term Debt BusinessAcquisitionPurchasePriceAllocationNotesPayableAndLongTermDebt	1000	USD
CY2011	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-4700000	USD
CY2012Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability	1000000	USD
CY2013	us-gaap	Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh	926000	USD
CY2012	us-gaap	Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh	2370000	USD
CY2011	us-gaap	Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value Low BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueLow	109000	USD
CY2013Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	6000	USD
CY2012Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	6000	USD
CY2013Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	26000	USD
CY2012Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	51000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	47787000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32807000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11433000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6891000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	47240000	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	21374000	USD
CY2011	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	4542000	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	14980000	USD
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	83595837	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	110100701	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	109425701	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	82920837	shares
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	10000	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2013Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	2.47
CY2013Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	2.50
CY2013Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	0.35	shares
CY2013Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	14850000	shares
CY2012Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	13216000	shares
CY2011Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	14121000	shares
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2011Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1.28
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2013	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:65px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentrations of Credit Risk</font><font style="font-family:inherit;font-size:10pt;"> — Financial instruments that potentially subject the company to significant concentrations of credit risk consist principally of cash and cash equivalents. The company maintains cash balances in several accounts with two banks, which at times are in excess of federally insured limits. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2013</font><font style="font-family:inherit;font-size:10pt;">, the company’s cash equivalents were invested in money market mutual funds. The company’s investment policy does not allow investment in any debt securities rated less than “investment grade” by national ratings services. The company has not experienced any losses on its deposits of cash and cash equivalents.</font></div></div>
CY2013Q4	us-gaap	Contractual Obligation Due In Fifth Year ContractualObligationDueInFifthYear	6935000	USD
CY2013Q4	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	432000	USD
CY2013Q4	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	847000	USD
CY2013Q4	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	724000	USD
CY2013Q4	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	533000	USD
CY2011	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
CY2012	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
CY2013	us-gaap	Cost Of Revenue CostOfRevenue	520000	USD
CY2012	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2012	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2013Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	15000000	USD
CY2013Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0845
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	894000	USD
CY2012	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-894000	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1052000	USD
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1052000	USD
CY2013Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	5053000	USD
CY2012Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	5053000	USD
CY2012	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-1052000	USD
CY2011	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits		USD
CY2013	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	1052000	USD
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	158000	USD
CY2012	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-158000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	41591000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	54104000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	-5053000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	-5053000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	33539000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	23632000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	83900000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	49800000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Other Tax Carryforwards DeferredTaxAssetsOtherTaxCarryforwards	12000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Other Tax Carryforwards DeferredTaxAssetsOtherTaxCarryforwards	-328000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	3201000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	3549000	USD
CY2013Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.46
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.52
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2012Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.85
CY2011	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.32
CY2012	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.56
CY2013Q2	us-gaap	Gross Profit GrossProfit	0	USD
CY2012Q3	us-gaap	Gross Profit GrossProfit	0	USD
CY2013Q3	us-gaap	Gross Profit GrossProfit	869000	USD
CY2012Q2	us-gaap	Gross Profit GrossProfit	0	USD
CY2013Q4	us-gaap	Gross Profit GrossProfit	967000	USD
CY2012Q1	us-gaap	Gross Profit GrossProfit	0	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	7944000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	8322000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	41591000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	54104000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts	5053000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts	5053000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	0	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	1052000	USD
CY2013	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	35000	USD
CY2011	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	USD
CY2012	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	0	USD
CY2012Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	74000	USD
CY2013Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	115000	USD
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	163000	USD
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	49000	USD
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	452000	USD
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2012Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1999000	USD
CY2012Q4	us-gaap	Gross Profit GrossProfit	0	USD
CY2011	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3407000	USD
CY2013	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-76678000	USD
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	217000	USD
CY2013Q2	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0.0000
CY2013Q2	us-gaap	Fair Value Assumptions Expected Term FairValueAssumptionsExpectedTerm	P7Y
CY2013Q2	us-gaap	Fair Value Assumptions Expected Volatility Rate FairValueAssumptionsExpectedVolatilityRate	0.7534
CY2013Q2	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0120
CY2013	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
CY2012	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
CY2011	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-7000	USD
CY2013	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	3911000	USD
CY2012	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	0	USD
CY2011	us-gaap	Gain Loss On Sale Of Securities Net GainLossOnSaleOfSecuritiesNet	0	USD
CY2013Q4	us-gaap	Goodwill Goodwill	5898000	USD
CY2012Q4	us-gaap	Goodwill Goodwill	5898000	USD
CY2013Q1	us-gaap	Gross Profit GrossProfit	0	USD
CY2012	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-33325000	USD
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3407000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-75626000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-34377000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.53
CY2013	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.85
CY2011	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.09
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1644000	USD
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
CY2011	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-8078000	USD
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.03
CY2011	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.22
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1052000	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1052000	USD
CY2011	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2012	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	8939000	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	11408000	USD
CY2013	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-25713000	USD
CY2012	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-11688000	USD
CY2012	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	152000	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	813000	USD
CY2012	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	0	USD
CY2013	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	125000	USD
CY2012	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1067000	USD
CY2013	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-3676000	USD
CY2012	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	0	USD
CY2013	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	240000	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	641000	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	684000	USD
CY2011	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	500000	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3683000	USD
CY2012	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	USD
CY2011	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	USD
CY2012	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-139000	USD
CY2011	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2154000	USD
CY2013	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	6726000	USD
CY2011	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	USD
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	386000	USD
CY2012	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	USD
CY2012	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	396000	USD
CY2011	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	99000	USD
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	832000	USD
CY2011	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	101000	USD
CY2012	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash		USD
CY2013	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	99000	USD
	us-gaap	Interest Paid InterestPaid	1000	USD
CY2011	us-gaap	Interest Paid InterestPaid	6000	USD
CY2013	us-gaap	Interest Paid InterestPaid	547000	USD
CY2012Q4	us-gaap	Interest Payable Current InterestPayableCurrent	0	USD
CY2013Q4	us-gaap	Interest Payable Current InterestPayableCurrent	70000	USD
CY2013Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	116000	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	386000	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	0	USD
CY2013Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	270000	USD
CY2012	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	364000	USD
CY2013	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	211000	USD
CY2011	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	73000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	82090000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	27230000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	54986000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	87976000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	62447000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15919000	USD
CY2013Q4	us-gaap	Long Term Debt LongTermDebt	10000000	USD
CY2012Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2013Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2149000	USD
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	2149000	USD
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	3913000	USD
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	3938000	USD
CY2013Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7743000	USD
CY2012Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2012Q4	us-gaap	Marketable Securities MarketableSecurities	2678000	USD
CY2013Q4	us-gaap	Marketable Securities MarketableSecurities	0	USD
CY2011	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	0	USD
CY2012	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	0	USD
CY2013	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	3911000	USD
CY2013	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	2678000	USD
CY2011	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss		USD
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-2678000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	55924000	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19196000	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	42424000	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	14000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-12036000	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-87000	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14668000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20963000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-28908000	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	-11485000	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-34969000	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-76678000	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	-24761000	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-9287000	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	-196000	USD
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	-48501000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-9293000	USD
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	-6261000	USD
CY2012Q4	us-gaap	Net Income Loss NetIncomeLoss	-3751000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-9597000	USD
CY2011	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	9079000	USD
CY2012	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13178000	USD
CY2013	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-41786000	USD
CY2011	us-gaap	Operating Expenses OperatingExpenses	12486000	USD
CY2013	us-gaap	Operating Expenses OperatingExpenses	36327000	USD
CY2012	us-gaap	Operating Expenses OperatingExpenses	21199000	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-33840000	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	-21199000	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	-12486000	USD
CY2011	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-11485000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-78304000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-33343000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeBeforeTax	-2678000	USD
CY2011	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeBeforeTax	0	USD
CY2012	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeBeforeTax	0	USD
CY2013	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax	-1626000	USD
CY2011	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeTax	0	USD
CY2013	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeTax	-1052000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Tax OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeTax	0	USD
CY2011	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax		USD
CY2012	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	2678000	USD
CY2013	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax		USD
CY2012	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1626000	USD
CY2011	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
CY2013	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
CY2012	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	1052000	USD
CY2011	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9086000	USD
CY2013	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-40979000	USD
CY2012	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-13145000	USD
CY2011	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants		USD
CY2013	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants		USD
CY2012	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	266000	USD
CY2012	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		USD
CY2013	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	15143000	USD
CY2011	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		USD
CY2013Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	10000000	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		USD
CY2011	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	53000	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	705000	USD
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue		USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	535000	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1399000	USD
CY2013	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:65px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:65px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassifications</font><font style="font-family:inherit;font-size:10pt;"> — Certain prior year amounts have been reclassified to conform to current year presentation. These reclassifications had no effect on net loss per share.</font></div></div>
CY2013	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	19000	USD
	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	1000	USD
CY2011	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	2000	USD
CY2011	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	18615000	USD
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	37539000	USD
CY2012	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	36378000	USD
CY2013	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	9865000	USD
CY2012	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2011	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2013Q3	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	5200000	USD
CY2013Q3	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	35000000	USD
CY2012Q4	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	24300000	USD
CY2012Q2	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	14600000	USD
CY2012	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
CY2013	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	3911000	USD
CY2011	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
CY2013	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	567000	USD
CY2011	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		USD
CY2012	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	21000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	665000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	29000	USD
CY2013	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	25000	USD
CY2011	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	84000	USD
CY2012	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	10000	USD
CY2013	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	21076000	USD
CY2012	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	14614000	USD
CY2011	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	3851000	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	101000	USD
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	200000	USD
CY2013	us-gaap	Sales Discounts Services SalesDiscountsServices	0	USD
CY2011	us-gaap	Sales Revenue Net SalesRevenueNet	0	USD
CY2012	us-gaap	Sales Revenue Net SalesRevenueNet	0	USD
CY2013	us-gaap	Sales Revenue Net SalesRevenueNet	2487000	USD
CY2012Q3	us-gaap	Sales Revenue Net SalesRevenueNet	0	USD
CY2013Q3	us-gaap	Sales Revenue Net SalesRevenueNet	1170000	USD
CY2012Q2	us-gaap	Sales Revenue Net SalesRevenueNet	0	USD
CY2013Q4	us-gaap	Sales Revenue Net SalesRevenueNet	1317000	USD
CY2012Q1	us-gaap	Sales Revenue Net SalesRevenueNet	0	USD
CY2013Q2	us-gaap	Sales Revenue Net SalesRevenueNet	0	USD
CY2013Q1	us-gaap	Sales Revenue Net SalesRevenueNet	0	USD
CY2012Q4	us-gaap	Sales Revenue Net SalesRevenueNet	0	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	2530000	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	1394000	USD
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	3001000	USD
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.7576
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.7798
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0157
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0105
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	6557000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.63
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1337000	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	7113000	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.70
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.98
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	30537000	USD
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2288000	USD
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7672000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	13159000	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.54
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.73
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.21
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.80
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.87
CY2013Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	16376000	USD
CY2012Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1394000	USD
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y9M4D
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y4M17D
CY2011	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y10M13D
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y10M13D
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y1M17D
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M
CY2012Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3849000	USD
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3849000	USD
CY2013Q3	us-gaap	Share Price SharePrice	2.00
CY2011	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y6M22D
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y1M2D
CY2013	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P10Y
CY2013	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	243510	shares
CY2013Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	17500000	shares
CY2012Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	9751000	shares
CY2012Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	1315849	shares
CY2013	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	289000	shares
CY2011	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	6367000	USD
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	USD
CY2013	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	USD
CY2013	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	22064000	USD
CY2011	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3270000	USD
CY2012	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	16551000	USD
CY2013	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	163000	USD
CY2012	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	93000	USD
CY2011	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	15000	USD
CY2013	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	211000	USD
CY2013	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	37539000	USD
CY2011	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	18615000	USD
CY2012	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	36378000	USD
CY2011	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	256000	USD
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	567000	USD
CY2012	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	21000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	5886000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	27756000	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5886000	USD
CY2010Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2430000	USD
CY2011Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10112000	USD
CY2012Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	27756000	USD
CY2012Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	675000	shares
CY2013Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	675000	shares
CY2013	gale	Aggregate Intrinsic Value Of Stock Options Exercisable AggregateIntrinsicValueOfStockOptionsExercisable	890000	USD
CY2012	gale	Aggregate Intrinsic Value Of Stock Options Exercisable AggregateIntrinsicValueOfStockOptionsExercisable	18000	USD
CY2013	gale	Amortization Period Of Selling And Distribution Rights AmortizationPeriodOfSellingAndDistributionRights	P10Y
CY2011	gale	Business Acquisition Pro Forma Earnings Per Share Basicand Diluted BusinessAcquisitionProFormaEarningsPerShareBasicandDiluted	-0.34
CY2011	gale	Business Acquisition Proforma Earnings Per Share Basic From Discontinued Operation BusinessAcquisitionProformaEarningsPerShareBasicFromDiscontinuedOperation	-0.21
CY2011Q4	gale	Business Acquisition Purchase Price Allocation In Process Research And Development BusinessAcquisitionPurchasePriceAllocationInProcessResearchAndDevelopment	12864000	USD
CY2011	gale	Business Acquisitions Proforma Net Income Loss From Discontinued Operation BusinessAcquisitionsProformaNetIncomeLossFromDiscontinuedOperation	-8078000	USD
CY2011	gale	Cash Excluding From Net Assets Acquired CashExcludingFromNetAssetsAcquired	168000	USD
CY2012Q3	gale	Cash Paid For Interest On Final Milestone CashPaidForInterestOnFinalMilestone	35000	USD
CY2013Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	108000	USD
CY2013	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:65px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Uses of Estimates in Preparation of Financial Statements</font><font style="font-family:inherit;font-size:10pt;"> — The preparation of these consolidated financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.</font></div></div>
CY2013	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	12500000	USD
CY2012	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	5100000	USD
CY2012	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	62480666	shares
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	90181501	shares
CY2011	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	36334413	shares
CY2013	gale	Cash Received In Acquisition CashReceivedInAcquisition	0	USD
CY2011	gale	Cash Received In Acquisition CashReceivedInAcquisition	-168000	USD
CY2012	gale	Cash Received In Acquisition CashReceivedInAcquisition	0	USD
CY2011	gale	Cash Transferred With Spin Off Transaction CashTransferredWithSpinOffTransaction		USD
CY2012	gale	Cash Transferred With Spin Off Transaction CashTransferredWithSpinOffTransaction	87000	USD
CY2013	gale	Cash Transferred With Spin Off Transaction CashTransferredWithSpinOffTransaction		USD
CY2013	gale	Change In Fair Value Of Common Stock Warrants Issued In Connection With Various Equity Financings ChangeInFairValueOfCommonStockWarrantsIssuedInConnectionWithVariousEquityFinancings	-44001000	USD
CY2012	gale	Change In Fair Value Of Common Stock Warrants Issued In Connection With Various Equity Financings ChangeInFairValueOfCommonStockWarrantsIssuedInConnectionWithVariousEquityFinancings	-10775000	USD
CY2011	gale	Change In Fair Value Of Common Stock Warrants Issued In Connection With Various Equity Financings ChangeInFairValueOfCommonStockWarrantsIssuedInConnectionWithVariousEquityFinancings	8981000	USD
CY2012	gale	Change In Fair Value Of Contingent Purchase Consideration ChangeInFairValueOfContingentPurchaseConsideration	-2370000	USD
CY2011	gale	Change In Fair Value Of Contingent Purchase Consideration ChangeInFairValueOfContingentPurchaseConsideration	109000	USD
CY2013	gale	Change In Fair Value Of Contingent Purchase Consideration ChangeInFairValueOfContingentPurchaseConsideration	-926000	USD
CY2011	gale	Change In Fair Value Of Contingent Purchase Price Consideration ChangeInFairValueOfContingentPurchasePriceConsideration	-109000	USD
CY2012	gale	Change In Fair Value Of Contingent Purchase Price Consideration ChangeInFairValueOfContingentPurchasePriceConsideration	2370000	USD
CY2013	gale	Change In Fair Value Of Contingent Purchase Price Consideration ChangeInFairValueOfContingentPurchasePriceConsideration	926000	USD
CY2012	gale	Change In Fair Value Of Warrant Liabilities ChangeInFairValueOfWarrantLiabilities	10775000	USD
CY2013	gale	Change In Fair Value Of Warrant Liabilities ChangeInFairValueOfWarrantLiabilities	44012000	USD
CY2011	gale	Changeinfairvalueofwarrantspotentiallysettleableincash Changeinfairvalueofwarrantspotentiallysettleableincash	-8986000	USD
CY2013	gale	Changeinfairvalueofwarrantspotentiallysettleableincash Changeinfairvalueofwarrantspotentiallysettleableincash	44001000	USD
CY2012	gale	Changeinfairvalueofwarrantspotentiallysettleableincash Changeinfairvalueofwarrantspotentiallysettleableincash	10775000	USD
CY2012Q4	gale	Class Of Warrant Or Right Exercise Price Of Warrants ClassOfWarrantOrRightExercisePriceOfWarrants	1.90
CY2012Q4	gale	Class Of Warrant Or Right Exercise Price Of Warrants Under Underwritten Public Offering ClassOfWarrantOrRightExercisePriceOfWarrantsUnderUnderwrittenPublicOffering	1.60
CY2012	gale	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	8883000	shares
CY2013	gale	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	5402000	shares
CY2012Q4	gale	Contingent Purchase Price Consideration Net Of Current Portion ContingentPurchasePriceConsiderationNetOfCurrentPortion	6207000	USD
CY2012Q4	gale	Contract Research Payable ContractResearchPayable	1705000	USD
CY2013Q4	gale	Contract Research Payable ContractResearchPayable	3109000	USD
CY2013Q2	gale	Classof Warrantor Right Average Market Price Used For Exercise Price ClassofWarrantorRightAverageMarketPriceUsedForExercisePrice	P20D
CY2013	gale	Classof Warrantor Right Expired ClassofWarrantorRightExpired	190000	shares
CY2012	gale	Classof Warrantor Right Granted ClassofWarrantorRightGranted	7978000	shares
CY2013	gale	Classof Warrantor Right Granted ClassofWarrantorRightGranted	7226000	shares
CY2013Q2	gale	Classof Warrantor Right Term ClassofWarrantorRightTerm	P7Y
CY2013	gale	Common Stock Issued In Connection With Espp CommonStockIssuedInConnectionWithEspp	-163000	USD
CY2012	gale	Common Stock Issued In Connection With Espp CommonStockIssuedInConnectionWithEspp	-93000	USD
CY2011	gale	Common Stock Issued In Connection With Espp CommonStockIssuedInConnectionWithEspp	-15000	USD
CY2013Q4	gale	Concentration Risk Numberof Customers ConcentrationRiskNumberofCustomers	3	customers
CY2013Q4	gale	Contingent Purchase Price Consideration Net Of Current Portion ContingentPurchasePriceConsiderationNetOfCurrentPortion	6821000	USD
CY2013Q4	gale	Contractual Obligations Current Due ContractualObligationsCurrentDue	9471000	USD
CY2012Q4	gale	Current Contingent Purchase Price Consideration CurrentContingentPurchasePriceConsideration	935000	USD
CY2013Q4	gale	Current Contingent Purchase Price Consideration CurrentContingentPurchasePriceConsideration	0	USD
CY2013Q2	gale	Debt Instrument Cash Facility Fee DebtInstrumentCashFacilityFee	0.01
CY2013Q2	gale	Debt Instrument Cash Final Payment DebtInstrumentCashFinalPayment	0.055
CY2013Q2	gale	Debt Instrument Term DebtInstrumentTerm	P30M
CY2013Q2	gale	Debt Instrument Term Interest Only DebtInstrumentTermInterestOnly	P12M
CY2013Q4	gale	Deferred Tax Assets Licensing Deduction Deferral DeferredTaxAssetsLicensingDeductionDeferral	8682000	USD
CY2012Q4	gale	Deferred Tax Assets Licensing Deduction Deferral DeferredTaxAssetsLicensingDeductionDeferral	8194000	USD
CY2013Q4	gale	Deficit Accumulated During Developmental Stage DeficitAccumulatedDuringDevelopmentalStage	-178875000	USD
CY2012Q4	gale	Deficit Accumulated During Developmental Stage DeficitAccumulatedDuringDevelopmentalStage	-102197000	USD
CY2013	gale	Employee Service Share Based Compensation Unrecognized Compensation Costs EmployeeServiceShareBasedCompensationUnrecognizedCompensationCosts	12033000	USD
CY2013	gale	Employee Service Share Based Compensation Unrecognized Compensation Costs Weighted Average Period Of Recognition EmployeeServiceShareBasedCompensationUnrecognizedCompensationCostsWeightedAveragePeriodOfRecognition	P2Y9M11D
CY2013	gale	Estimated Annualized Forfeiture Rate For Options Granted To Employees EstimatedAnnualizedForfeitureRateForOptionsGrantedToEmployees	0.15
CY2013	gale	Estimated Annualized Forfeiture Rate For Options Granted To Senior Management EstimatedAnnualizedForfeitureRateForOptionsGrantedToSeniorManagement	0.08
CY2011Q4	gale	Estimated Value Of Earn Out EstimatedValueOfEarnOut	6460000	USD
CY2011Q2	gale	Estimated Value Of Earn Out EstimatedValueOfEarnOut	6460000	USD
CY2012	gale	Expense Recognized For Change In Fair Value ExpenseRecognizedForChangeInFairValue	579000	USD
CY2013	gale	Fair Value Of Contingent Purchase Price Consideration FairValueOfContingentPurchasePriceConsideration	0	USD
CY2011	gale	Fair Value Of Contingent Purchase Price Consideration FairValueOfContingentPurchasePriceConsideration	6460000	USD
	gale	Fair Value Of Contingent Purchase Price Consideration FairValueOfContingentPurchasePriceConsideration	0	USD
CY2013	gale	Fair Value Of Parent Company Common Stock Issued In Exchange For Services FairValueOfParentCompanyCommonStockIssuedInExchangeForServices		USD
CY2012	gale	Fair Value Of Parent Company Common Stock Issued In Exchange For Services FairValueOfParentCompanyCommonStockIssuedInExchangeForServices	0	USD
CY2011	gale	Fair Value Of Parent Company Common Stock Issued In Exchange For Services FairValueOfParentCompanyCommonStockIssuedInExchangeForServices	108000	USD
CY2011Q4	gale	Fair Value Of Shares Issued At Closing Including Escrowed Shares Expected To Be Released FairValueOfSharesIssuedAtClosingIncludingEscrowedSharesExpectedToBeReleased	6367000	USD
CY2012	gale	Fair Value Of Warrants Exercised FairValueOfWarrantsExercised	-10843000	USD
CY2013	gale	Fair Value Of Warrants Exercised FairValueOfWarrantsExercised	14249000	USD
CY2011	gale	Fair Value Of Warrants Issued In Connection With Common Stock Recorded As Cost Of Equity FairValueOfWarrantsIssuedInConnectionWithCommonStockRecordedAsCostOfEquity	12709000	USD
	gale	Fair Value Of Warrants Issued In Connection With Common Stock Recorded As Cost Of Equity FairValueOfWarrantsIssuedInConnectionWithCommonStockRecordedAsCostOfEquity	7286000	USD
CY2013	gale	Fair Value Of Warrants Issued In Connection With Common Stock Recorded As Cost Of Equity FairValueOfWarrantsIssuedInConnectionWithCommonStockRecordedAsCostOfEquity	8238000	USD
CY2012Q4	gale	Fair Value Of Warrants Liabilities FairValueOfWarrantsLiabilities	10964000	USD
CY2011Q4	gale	Fair Value Of Warrants Liabilities FairValueOfWarrantsLiabilities	3746000	USD
CY2013Q3	gale	Fair Value Of Warrants Liabilities FairValueOfWarrantsLiabilities	48965000	USD
CY2012Q4	gale	Fair Value Of Warrants Potentially Settleable In Cash FairValueOfWarrantsPotentiallySettleableInCash	10964000	USD
CY2013Q4	gale	Fair Value Of Warrants Potentially Settleable In Cash FairValueOfWarrantsPotentiallySettleableInCash	48965000	USD
CY2012	gale	Fair Valueof Warrants Granted FairValueofWarrantsGranted	7286000	USD
CY2013	gale	Fair Valueof Warrants Granted FairValueofWarrantsGranted	8238000	USD
CY2013Q2	gale	Fair Valueof Warrants Grantedper Share FairValueofWarrantsGrantedperShare	1.93
CY2012	gale	General And Administrative Employee Stock Based Compensation GeneralAndAdministrativeEmployeeStockBasedCompensation	0	USD
CY2013	gale	General And Administrative Employee Stock Based Compensation GeneralAndAdministrativeEmployeeStockBasedCompensation	131000	USD
CY2011	gale	General And Administrative Employee Stock Based Compensation GeneralAndAdministrativeEmployeeStockBasedCompensation	0	USD
CY2011	gale	General And Administrative Expenses GeneralAndAdministrativeExpenses	8635000	USD
CY2012	gale	General And Administrative Expenses GeneralAndAdministrativeExpenses	6585000	USD
CY2013	gale	General And Administrative Expenses GeneralAndAdministrativeExpenses	14600000	USD
CY2013Q4	gale	In Process Research Development InProcessResearchDevelopment	12864000	USD
CY2012Q4	gale	In Process Research Development InProcessResearchDevelopment	12864000	USD
CY2013	gale	Income Tax Reconciliation Gain On Change In Fair Value Of Warrant Liability IncomeTaxReconciliationGainOnChangeInFairValueOfWarrantLiability	17283000	USD
CY2012	gale	Income Tax Reconciliation Gain On Change In Fair Value Of Warrant Liability IncomeTaxReconciliationGainOnChangeInFairValueOfWarrantLiability	3664000	USD
CY2012	gale	Income Tax Reconciliation Unrealized Gain On Marketable Securities IncomeTaxReconciliationUnrealizedGainOnMarketableSecurities	-1052000	USD
CY2013	gale	Income Tax Reconciliation Unrealized Gain On Marketable Securities IncomeTaxReconciliationUnrealizedGainOnMarketableSecurities	1052000	USD
CY2013Q4	gale	Increase Decrease Deferred Tax Assets IncreaseDecreaseDeferredTaxAssets	-109000	USD
CY2012Q1	gale	Increase In Number Of Milestone Shares If Shareholders Approval Is Obtained IncreaseInNumberOfMilestoneSharesIfShareholdersApprovalIsObtained	0.76
CY2013	gale	Interest Income InterestIncome	-807000	USD
CY2012	gale	Interest Income InterestIncome	-33000	USD
CY2011	gale	Interest Income InterestIncome	-7000	USD
CY2011	gale	Issuance Of Common Stock In Exchange Of Outstanding Warrants IssuanceOfCommonStockInExchangeOfOutstandingWarrants	-3120000	USD
	gale	Issuance Of Common Stock In Exchange Of Outstanding Warrants IssuanceOfCommonStockInExchangeOfOutstandingWarrants	0	USD
CY2013	gale	Issuance Of Common Stock In Exchange Of Outstanding Warrants IssuanceOfCommonStockInExchangeOfOutstandingWarrants	0	USD
CY2013	gale	Issuance Of Common Stock In Settlement Of Contingent Purchase Consideration Milestone IssuanceOfCommonStockInSettlementOfContingentPurchaseConsiderationMilestone	1247000	USD
CY2012	gale	Issuance Of Common Stock In Settlement Of Contingent Purchase Consideration Milestone IssuanceOfCommonStockInSettlementOfContingentPurchaseConsiderationMilestone	1579000	USD
CY2011	gale	Issuance Of Common Stock In Settlement Of Contingent Purchase Consideration Milestone IssuanceOfCommonStockInSettlementOfContingentPurchaseConsiderationMilestone		USD
	gale	Issuance Of Common Stock In Settlement Of Contingent Purchase Consideration Milestone IssuanceOfCommonStockInSettlementOfContingentPurchaseConsiderationMilestone	1579000	USD
CY2013Q4	gale	Longterm Debt Netof Unamortized Issuance Costs LongtermDebtNetofUnamortizedIssuanceCosts	9892000	USD
CY2013Q2	gale	M Ilestone Payment MIlestonePayment	1247000	USD
CY2013	gale	M Ilestone Payment MIlestonePayment	2000000	USD
CY2013	gale	Maximum Maturity Period To Consider All Highly Liquid Debt Instruments As Cash And Cash Equivalents MaximumMaturityPeriodToConsiderAllHighlyLiquidDebtInstrumentsAsCashAndCashEquivalents	P90D
CY2012	gale	Maximum Percentage Of Deferred Tax Asset To Establishes Valuation Allowance MaximumPercentageOfDeferredTaxAssetToEstablishesValuationAllowance	1.00
CY2013	gale	Miscellaneous Other Income Expense MiscellaneousOtherIncomeExpense	37000	USD
CY2011	gale	Miscellaneous Other Income Expense MiscellaneousOtherIncomeExpense	-9000	USD
CY2012	gale	Miscellaneous Other Income Expense MiscellaneousOtherIncomeExpense	0	USD
CY2012	gale	Net Liabilities Distributed To Common Stock Holders In Rxi Spin Off Net Of Cash Transferred In Spin Off NetLiabilitiesDistributedToCommonStockHoldersInRxiSpinOffNetOfCashTransferredInSpinOff	2159000	USD
	gale	Net Liabilities Distributed To Common Stock Holders In Rxi Spin Off Net Of Cash Transferred In Spin Off NetLiabilitiesDistributedToCommonStockHoldersInRxiSpinOffNetOfCashTransferredInSpinOff	2246000	USD
CY2011	gale	Net Liabilities Distributed To Common Stock Holders In Rxi Spin Off Net Of Cash Transferred In Spin Off NetLiabilitiesDistributedToCommonStockHoldersInRxiSpinOffNetOfCashTransferredInSpinOff	0	USD
CY2013	gale	Net Liabilities Distributed To Common Stock Holders In Rxi Spin Off Net Of Cash Transferred In Spin Off NetLiabilitiesDistributedToCommonStockHoldersInRxiSpinOffNetOfCashTransferredInSpinOff	0	USD
CY2012	gale	Net Proceeds From Exercise Of Common Stock Warrants NetProceedsFromExerciseOfCommonStockWarrants	5708000	USD
CY2013	gale	Net Proceeds From Exercise Of Common Stock Warrants NetProceedsFromExerciseOfCommonStockWarrants	7815000	USD
CY2011	gale	Net Proceeds From Exercise Of Common Stock Warrants NetProceedsFromExerciseOfCommonStockWarrants	150000	USD
CY2011	gale	Net Proceeds From Issuance Of Convertible Notes Payable NetProceedsFromIssuanceOfConvertibleNotesPayable	-500000	USD
CY2013	gale	Net Proceeds From Issuance Of Convertible Notes Payable NetProceedsFromIssuanceOfConvertibleNotesPayable		USD
CY2012	gale	Net Proceeds From Issuance Of Convertible Notes Payable NetProceedsFromIssuanceOfConvertibleNotesPayable	-500000	USD
CY2013Q4	gale	Numberof Commerical Products NumberofCommericalProducts	1	products
CY2013Q2	gale	Numberof Days Averagedfor Exercise Price NumberofDaysAveragedforExercisePrice	P20D
CY2013Q4	gale	Numberof Dosing Strengths NumberofDosingStrengths	6	dosing_strength
CY2013Q3	gale	Numberof Shares Per Unit NumberofSharesPerUnit	1	shares
CY2012	gale	Operating Lease Expense OperatingLeaseExpense	139000	USD
CY2011	gale	Operating Lease Expense OperatingLeaseExpense	233000	USD
CY2013	gale	Operating Lease Expense OperatingLeaseExpense	77000	USD
CY2013Q4	gale	Operating Loss Carryforwards Exerciseof Stock Options OperatingLossCarryforwardsExerciseofStockOptions	280000	USD
CY2012Q4	gale	Patient Assistance Program Current PatientAssistanceProgramCurrent	0	USD
CY2013Q4	gale	Patient Assistance Program Current PatientAssistanceProgramCurrent	2618000	USD
CY2012Q1	gale	Payment To Former Shareholders In Cash At Interest Factor PaymentToFormerShareholdersInCashAtInterestFactor	0.10
CY2012Q2	gale	Proceeds From Issuanceor Saleof Equity Net Underwriting Discounts Commissionsand Offering Expenses ProceedsFromIssuanceorSaleofEquityNetUnderwritingDiscountsCommissionsandOfferingExpenses	13500000	USD
CY2013Q3	gale	Proceeds From Issuanceor Saleof Equity Net Underwriting Discounts Commissionsand Offering Expenses ProceedsFromIssuanceorSaleofEquityNetUnderwritingDiscountsCommissionsandOfferingExpenses	37500000	USD
CY2012Q4	gale	Proceeds From Issuanceor Saleof Equity Net Underwriting Discounts Commissionsand Offering Expenses ProceedsFromIssuanceorSaleofEquityNetUnderwritingDiscountsCommissionsandOfferingExpenses	22500000	USD
CY2013	gale	Proceedsfromsaleofsharesafterspinoff Proceedsfromsaleofsharesafterspinoff	3911000	USD
CY2012	gale	Reclassification Of Warrant Liability Upon Exercise ReclassificationOfWarrantLiabilityUponExercise	10843000	USD
	gale	Reclassification Of Warrant Liability Upon Exercise ReclassificationOfWarrantLiabilityUponExercise	-10843000	USD
CY2013	gale	Reclassification Of Warrant Liability Upon Exercise ReclassificationOfWarrantLiabilityUponExercise	-14249000	USD
CY2011	gale	Reclassification Of Warrant Liability Upon Exercise ReclassificationOfWarrantLiabilityUponExercise		USD
CY2012	gale	Repurchase Of Common Stock Warrant RepurchaseOfCommonStockWarrant	266000	USD
CY2013Q4	gale	Sales And Distributions Rights SalesAndDistributionsRights	14979000	USD
CY2012Q4	gale	Sales And Distributions Rights SalesAndDistributionsRights		USD
CY2013Q2	gale	Shares Issuedfor Milestone Payment SharesIssuedforMilestonePayment	492988	shares
CY2011	gale	Stock Issued During Period Value Cash Bonus StockIssuedDuringPeriodValueCashBonus	171000	USD
CY2011	gale	Stock Issued During Period Value Employee Termination Agreements StockIssuedDuringPeriodValueEmployeeTerminationAgreements	350000	USD
CY2012	gale	Stock Issued During Period Value Services StockIssuedDuringPeriodValueServices	364000	USD
CY2011	gale	Stock Issued During Period Value Services StockIssuedDuringPeriodValueServices	73000	USD
CY2012Q4	gale	Warrant To Purchase Share Of Common Stock WarrantToPurchaseShareOfCommonStock	0.50	shares
CY2013Q2	gale	Warrants Granted Numberof Shares WarrantsGrantedNumberofShares	182186	shares
CY2013	dei	Amendment Flag AmendmentFlag	false
CY2013	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2013	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013	dei	Document Period End Date DocumentPeriodEndDate	2013-12-31
CY2013	dei	Document Type DocumentType	10-K
CY2013	dei	Entity Central Index Key EntityCentralIndexKey	0001390478
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	117879459	shares
CY2013	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2013Q2	dei	Entity Public Float EntityPublicFloat	185711000	USD
CY2013	dei	Entity Registrant Name EntityRegistrantName	Galena Biopharma, Inc.
CY2013	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2013	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2013	dei	Trading Symbol TradingSymbol	GALE

Files In Submission

Name	View Source	Status
0001390478-14-000016-index-headers.html	Edgar Link	pending
0001390478-14-000016-index.html	Edgar Link	pending
0001390478-14-000016.txt	Edgar Link	pending
0001390478-14-000016-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gale-20131231.xml	Edgar Link	completed
gale-20131231.xsd	Edgar Link	pending
gale-20131231x10k.htm	Edgar Link	pending
gale-20131231xex102.htm	Edgar Link	pending
gale-20131231xex1036.htm	Edgar Link	pending
gale-20131231xex1037.htm	Edgar Link	pending
gale-20131231xex21.htm	Edgar Link	pending
gale-20131231xex211.htm	Edgar Link	pending
gale-20131231xex231.htm	Edgar Link	pending
gale-20131231xex232.htm	Edgar Link	pending
gale-20131231xex311.htm	Edgar Link	pending
gale-20131231xex312.htm	Edgar Link	pending
gale-20131231xex321.htm	Edgar Link	pending
gale-20131231xex49.htm	Edgar Link	pending
gale-20131231_cal.xml	Edgar Link	unprocessable
gale-20131231_def.xml	Edgar Link	unprocessable
gale-20131231_lab.xml	Edgar Link	unprocessable
gale-20131231_pre.xml	Edgar Link	unprocessable
performancegraphfinal10k.jpg	Edgar Link	pending
pipeline.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SLS
SELLAS Life Sciences Group, Inc. Stock $sls

2014 Q1 Form 10-K Financial Statement

#000139047814000016 Filed on March 17, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SLS SELLAS Life Sciences Group, Inc. Stock $sls

2014 Q1 Form 10-K Financial Statement

#000139047814000016 Filed on March 17, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SLS
SELLAS Life Sciences Group, Inc. Stock $sls